123 related articles for article (PubMed ID: 2120389)
1. Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect.
Lestienne P; Nelson J; Riederer P; Jellinger K; Reichmann H
J Neurochem; 1990 Nov; 55(5):1810-2. PubMed ID: 2120389
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA and Parkinson's disease.
Di Monte DA
Neurology; 1991 May; 41(5 Suppl 2):38-42; discussion 42-3. PubMed ID: 1904141
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial complex I deficiency in Parkinson's disease.
Schapira AH; Cooper JM; Dexter D; Clark JB; Jenner P; Marsden CD
J Neurochem; 1990 Mar; 54(3):823-7. PubMed ID: 2154550
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of the electron transport chain in idiopathic Parkinson's disease.
Parker WD; Boyson SJ; Parks JK
Ann Neurol; 1989 Dec; 26(6):719-23. PubMed ID: 2557792
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA analysis in Parkinson's disease.
Schapira AH; Holt IJ; Sweeney M; Harding AE; Jenner P; Marsden CD
Mov Disord; 1990; 5(4):294-7. PubMed ID: 1979656
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
Schapira AH; Mann VM; Cooper JM; Krige D; Jenner PJ; Marsden CD
Ann Neurol; 1992; 32 Suppl():S116-24. PubMed ID: 1510369
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial complex I deficiency in Parkinson's disease.
Schapira AH
Adv Neurol; 1993; 60():288-91. PubMed ID: 8420145
[No Abstract] [Full Text] [Related]
8. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.
Mizuno Y; Ohta S; Tanaka M; Takamiya S; Suzuki K; Sato T; Oya H; Ozawa T; Kagawa Y
Biochem Biophys Res Commun; 1989 Sep; 163(3):1450-5. PubMed ID: 2551290
[TBL] [Abstract][Full Text] [Related]
9. Iron-dependent enzymes in Parkinson's disease.
Reichmann H; Janetzky B; Riederer P
J Neural Transm Suppl; 1995; 46():157-64. PubMed ID: 8821051
[TBL] [Abstract][Full Text] [Related]
10. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome.
Reichmann H; Janetzky B; Bischof F; Seibel P; Schöls L; Kuhn W; Przuntek H
Eur Neurol; 1994; 34(5):263-7. PubMed ID: 7995300
[TBL] [Abstract][Full Text] [Related]
11. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.
Mann VM; Cooper JM; Krige D; Daniel SE; Schapira AH; Marsden CD
Brain; 1992 Apr; 115 ( Pt 2)():333-42. PubMed ID: 1606472
[TBL] [Abstract][Full Text] [Related]
12. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
Schapira AH
Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
[TBL] [Abstract][Full Text] [Related]
13. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
Schapira AH; Mann VM; Cooper JM; Dexter D; Daniel SE; Jenner P; Clark JB; Marsden CD
J Neurochem; 1990 Dec; 55(6):2142-5. PubMed ID: 2121905
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
15. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
[TBL] [Abstract][Full Text] [Related]
16. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease.
Li H; Dryhurst G
J Neurochem; 1997 Oct; 69(4):1530-41. PubMed ID: 9326282
[TBL] [Abstract][Full Text] [Related]
17. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Nakagawa-Hattori Y; Mochizuki H; Tanaka M; Ozawa T
Biochim Biophys Acta; 1995 May; 1271(1):265-74. PubMed ID: 7599219
[TBL] [Abstract][Full Text] [Related]
18. Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease.
Li H; Shen XM; Dryhurst G
J Neurochem; 1998 Nov; 71(5):2049-62. PubMed ID: 9798930
[TBL] [Abstract][Full Text] [Related]
19. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
[TBL] [Abstract][Full Text] [Related]
20. Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?
Ruberg M; Brugg B; Prigent A; Hirsch E; Brice A; Agid Y
J Neurochem; 1997 May; 68(5):2098-110. PubMed ID: 9109538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
